32
Participants
Start Date
August 31, 2015
Primary Completion Date
December 31, 2015
Study Completion Date
January 31, 2016
AX-024.HCl
AX-024.HCl will be administered as per the protocol defined frequency and dose level
AX-024.HCl
AX-024.HCl will be administered as per the protocol defined frequency and dose level
Simbec Research Ltd, Merthyr Tydfil
Lead Sponsor
Simbec Research
INDUSTRY
Artax Biopharma Inc
INDUSTRY